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The normal development and physiological functions of multicellular organisms are regulated by complex
gene transcriptional networks that include myriad transcription factors, their associating coregulators, and
multiple chromatin-modifying factors. Aberrant gene transcriptional regulation resulting from mutations
among these elements often leads to developmental defects and diseases.This review article concentrates
on the Atrophin family proteins, including vertebrate Atrophin-1 (ATN1), vertebrate arginine-glutamic acid
dipeptide repeats protein (RERE), and Drosophila Atrophin (Atro), which we recently identified as nuclear
receptor corepressors. Disruption of Atrophin-mediated pathways causes multiple developmental defects in
mouse, zebrafish, and Drosophila, while an aberrant form of ATN1 and altered expression levels of RERE are
associated with neurodegenerative disease and cancer in humans, respectively.We here provide an overview
of current knowledge about these Atrophin proteins.We hope that this information on Atrophin proteins may
help stimulate fresh ideas about how this newly identified class of nuclear receptor corepressors aids specific
nuclear receptors and other transcriptional factors in regulating gene transcription, manifesting physiological
effects, and causing diseases.
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Introduction
Atrophin proteins are conserved transcriptional
corepressors that, as we recently demonstrated, are
involved in nuclear receptor signaling.This review article
provides an overview of our current understanding of this
new class of nuclear receptor corepressors, which
includes vertebrate Atrophin-1 (ATN1), vertebrate arginine
glutamic acid repeats encoded protein (RERE), and
Drosophila Atrophin (Atro).
This review discusses the identification of atrophin
proteins, their expression and cellular patterns, their
connections with nuclear receptor and epidermal growth
factor signaling pathways, functional domains,
associations with histone modifying factors, roles in
animal development, and their implications in human
diseases. Deepening our understanding of the Atrophin
proteins will expand our insights about how these nuclear
receptor corepressors help transcriptional factors, such
as nuclear receptors, regulate gene transcription, exert
biological effects, and cause diseases.
The identification of atrophin proteins
The Atn1 gene was initially cloned by Christopher Ross’s
group at Johns Hopkins University as CTG-B37 in their
screens for human genes containing CTG/CAG or
CCG/CGG triplet repeats [Li et al., 1993]. In 1994, the
Atn1 gene was assigned to the short arm of chromosome
12 and was simultaneously reported by Masao Yamada
(National Children’s Medical Research Center, Japan)
and Shoji Tsuji (Niigata University, Japan) to be a
causative factor for the neurodegenerative disease
DRPLA (dentatorubral-pallidoluysian atrophy) when the
CAG repeat within the coding region of the Atn1 gene is
expanded [Koide et al., 1994; Nagafuchi et al., 1994]. In
addition to the glutamine-repeat (coded by the CAG
repeat), ATN1 also contains two arginine-glutamic acid
dipeptide-like repeats (RE-repeats) that reside at its
C-terminus. In search of potential ATN1 homologues,
Masao Yamada’s group identified RERE [Yanagisawa et
al., 2000], named after the RE-like repeats present at the
C-terminus of the protein. Owing to its resemblance with
ATN1, RERE has also been referred to as Atrophin-2.
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independently:Tian Xu’s group at Yale University, using
a dominant female sterile-FRT/FLP approach, identified
Atro during their search for lethal mutations that affect
growth and patterning [Zhang et al., 2002]; and Steve
Kerridge and Laurent Fansano’s group at the IBDML
(Marseille, France), isolated Atro through an EMS
mutagenesis in their screening for mutations that affect
the expression of the region-specific pattern gene teashirt
[Erkner et al., 2002]. In the latter study, Atro was also
referred to as Grunge. Drawing on their characterization
of Atro mutants, both groups reported that Atro is an
essential gene involved in multiple developmental
pathways.
Spatial and cellular patterns
Northern blot analysis reveals that Atn1 transcripts are
ubiquitously expressed in a variety of neuronal and
non-neuronal tissues, including brain, heart, lung, kidney,
placenta, skeletal muscle and liver [Kanazawa, 1998;
Onodera et al., 1995]. At the cellular level, ATN1 is
predominantly localized to the cytoplasm of neuronal cells
[Knight et al., 1997], although in cultured HeLa cells,
transiently expressed ATN1 was found to be present
within the nucleus [Okamura-Oho et al., 1999;
Yanagisawa et al., 2000].
The Rere gene codes for two transcripts with estimated
sizes of 7.4 and 9.4 kb.Their expression varies
considerably in different tissues, being particularly
abundant in the cerebellum, testis, uterus, prostate,
skeletal muscle and kidney, and relatively lower in lung,
colon and leukocytes [Waerner et al., 2001;Yanagisawa
et al., 2000].The cellular localization of RERE protein
was reported based on transient overexpression
conditions. In transfected HeLa cells, although a low level
of RERE can be detected in the cytoplasm, RERE
localizes predominantly to the nucleus, where it forms a
speckle-like pattern resembling that of promyelocytic
leukemia bodies [Waerner et al., 2001;Yanagisawa et
al., 2000].
In Drosophila, Atro is at first ubiquitously distributed
throughout the embryo during the early stage [Erkner et
al., 2002; Zhang et al., 2002]. During later stages of
embryogenesis, a higher level of Atro becomes more
apparent at the ventral nerve cord region. At the third
instar larvae stage, Atro resumes its ubiquitously
expressed pattern in various examined imaginal tissues.
Throughout different developmental stages, Atro mainly
localizes to the nucleus of cells, within which endogenous
Atro forms a speckle-like pattern [Zhang et al., 2002] .
When overexpressed in human cells, consistently, Atro
also forms a nuclear speckle pattern [Wang et al., 2008;
Wang et al., 2006], indicating that formation of a nuclear
speckle pattern is a shared property of Atro and RERE.
Interestingly, this unique cellular feature does not apply
to ATN1, probably because it lacks the SANT
(SWI3/ADA2/N-CoR/TFIII-B) domain (more information
about this domain will be provided below), which is
essential for RERE to form nuclear foci [Wang et al.,
2006].
Roles of atrophin proteins in animal and
Drosophila development
A recent study shows that Atn1 is not an essential gene
during mouse development, because Atn1 knockout
mouse is indistinguishable from wild-type mouse [Shen
et al., 2007]. In contrast, Rere is required for both mouse
and zebrafish to develop and to survive [Asai et al., 2006;
Plaster et al., 2007; Zoltewicz et al., 2004]. In mouse,
mutations of Rere cause a failure in closing the anterior
neural tube and fusion of the telencephalic and optic
vesicles during early embryogenesis [Zoltewicz et al.,
2004]. Other defects include a smaller first branchial arch
with a deficit in the mesenchymal component, a
fail-to-loop heart tube and somites with irregular shapes
and sizes. All homozygous mice die shortly after E9.5,
possibly owing to cardiac failure. Accompanying most of
these described phenotypes is the disruption of important
signaling centers, including the loss of sonic hedgehog
in the anterior notochord, and defective expression of
fibroblast growth factor 8 (fgf8) in the anterior neural ridge.
In zebrafish, modulations of Fgf8 signaling by RERE were
also observed in the context of posterior mesoderm
formation, midbrain-hindbrain boundary maintenance,
and the development of pharyngeal cartilage and inner
ear [Asai et al., 2006; Plaster et al., 2007].The apparently
divergent effects of ATN1 and RERE on animal
development suggest that their functions are not
equivalent. Since ATN1 resembles a truncated form of
RERE (Figure 1), the portion of RERE that is missing
from ATN1 could account for their functional differences.
As the Drosophila counterpart of RERE, Atro is also
crucial for the development of Drosophila. Embryos
deficient of maternal or both the maternal and zygotic
component of Atro exhibit severe segmentation defects
[Erkner et al., 2002; Kankel et al., 2004; Zhang et al.,
2002]. Such Atro mutant embryos also lack some ventral
patterning elements, and often show holes in the ventral
cuticle, suggesting that in addition to its better
characterized involvement in anterior-posterior patterning,
Atro also participates in dorsal-ventral axis patterning. In
embryos devoid of Atro protein (using a null Atro allele),
the expression patterns of several segmentation gap
genes, such as hunchback, Krüpple and knirps (kni), are
altered [Erkner et al., 2002;Wang et al., 2006].The
altered expression of gap genes can partly explain the
subsequent abnormal expression of pair-rule genes, such
as fushi-tarazu (ftz) and hairy. However, evidence from
experiments using hypomorphic Atro alleles reveals that
Atro also functions downstream of the gap genes. For
example, embryos derived from females carrying
hypomorphic Atro alleles do not show loss of continuous
segments (gap gene phenotype), but, instead, display
loss of even-numbered (ftz-dependent) engrailed stripes
[Kankel et al., 2004; Zhang et al., 2002]. Consistently,
the cuticles of such Atro mutant embryos also display
strong ftz-like segmentation defects. Although these
ftz-phenotypes could result from the loss of the repressive
activity of a pair-rule protein Even-skipped (Eve), as
suggested in [Zhang et al., 2002], other regulatory
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Review An overview of atrophin proteinsFigure 1.  A comparison of ATN1, RERE and Atro, and their functional domains. The boundaries and the percentage of identical/similar residues
within the conserved regions between human ATN1 (Atrophin-1), human RERE (arginine glutamic acid dipeptide repeats protein), and Drosophila Atro
(Atrophin) are shown.The functional domains, including BAH (bromo adjacent homology), ELM2 (EGL-27 and MTA1 homology 2), SANT
(SWI3/ADA2/N-CoR/TFIII-B), RE-repeat (arginine-glutamic acid dipeptide-repeat), ZnF-GATA, and glutamine (Q)-repeat are highlighted in different
colors.The mapped nuclear receptor interacting domains at the C-terminus of each protein are marked in dark blue, within which the Atro-box is labeled
as a white bar.The ELM2 domain and SANT domain are docking sites where HDAC1/2 (histone deacetylase 1, 2) and G9a (H3-K9 histone
methyltransferase) bind, respectively.
pathways that control the expression of ftz may be
affected by Atro mutations as well.
Atro is also involved in other developmental pathways.
For example, mutations of Atro affect planar polarity in
the eyes in a non-autonomous manner [Fanto et al., 2003;
Zhang et al., 2002], and also cause patterning defects in
the legs [Erkner et al., 2002;Wehn and Campbell, 2006].
Atro can antagonize the activity of EGFR (epidermal
growth factor receptor) as well [Charroux et al., 2006],
since in the Drosophila wing, mutation of Atro or reduced
expression of Atro results in ectopic vein formation
[Charroux et al., 2006; Kankel et al., 2004;Wang et al.,
2008]. (Note that wing vein formation is known to be
initiated by activated EGFR [Martin-Blanco et al., 1999]).
The possibility that Atro negatively regulates EGFR
signaling is further supported by the genetic interactions
between Atro and several key genetic components in the
EGFR signaling pathways, including argos, rolled,
pointed, and yan (anterior open), in both Drosophila wing
and eye [Charroux et al., 2006].
The function of Atro has also been connected with
microRNA. Steve Cohen’s group at Temasek, Singapore,
reported recently that Atro is a target of miR-8, after they
identified four potential miR-8 binding sites at the 3’
untranslated region (3’UTR) of the Atro gene [Karres et
al., 2007]. In support of their finding, the leg phenotype
displayed by mir-8 mutants is similar to that caused by
the overexpression of Atro [Charroux et al., 2006; Karres
et al., 2007]. Additionally, reducing Atro activity can
rescue the survival rate of these mir-8 mutant flies [Karres
et al., 2007]. Regulation of Atro by miR-8 appears to be
a conserved feature, because the same group found that
3’UTR of the Rere gene also contains three potential
targets of miR-429 and miR-200b, which are the
vertebrate counterparts of miR-8.Therefore, a key
function of miR-8 and miR-429/miR-200b may be to
fine-tune the expression levels of Atro and RERE in
Drosophila and in vertebrates. Consequently, altered
expression of miR-8, -200b, or -429 is expected to affect
the developmental pathways that are regulated by Atro
or RERE.
Roles in nuclear receptor signaling
Our lab recently defined Atrophin proteins as corepressors
of nuclear receptors through our work with Drosophila
Tailless (Tll) and vertebrate Tlx [Wang et al., 2006], which
are two closely related nuclear receptors belonging to the
2E subgroup of the nuclear receptor family (NURSA,
http://www.nursa.org/). An interaction between Tlx and
ATN1 was also reported by Ron Evans’ lab at the Salk
Institute [Zhang et al., 2006].
Tll is a gap protein involved in specifying terminal cell fate
during early embryogenesis [Mahoney and Lengyel, 1987;
Pignoni et al., 1990], and it is also implicated in
neurogenesis [Younossi-Hartenstein et al., 1997]. In
parallel with the roles of Tll in Drosophila nervous system
development, Tlx participates in regulating vertebrate
retinal and forebrain development [Miyawaki et al., 2004;
Roy et al., 2002; Zhang et al., 2006] and in maintaining
adult neural stem cells [Shi et al., 2004; Sun et al., 2007;
Zhang et al., 2008]. Both Tll and Tlx have long been
known to exert potent transcriptional repression [Hoch et
al., 1992; Pankratz et al., 1992; Pankratz et al., 1989;Yu
et al., 1994] and have been defined as dedicated
transcriptional repressors [Moran and Jimenez, 2006].
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remained unclear until our discovery of their association
with Atrophin proteins.
Our results show that Tll/Tlx-Atrophin interactions are
mediated through the ligand binding domain (LBD) of
Tll/Tlx and the C-terminal regions of the three Atrophin
proteins [Wang et al., 2006] (regions marked in blue,
Figure 1). In keeping with these observed physical
interactions between Tll/Tlx and Atrophin proteins, our in
vivo studies in Drosophila demonstrated that Atro indeed
assists Tll in repressing the expression of kni, a
segmentation gap gene known to be a direct target of Tll
[Pankratz et al., 1992].The following data indicate that
Atro is involved in the Tll-regulatory pathways: (1)
depletion of Atro from Drosophila embryos leads to
derepression of kni similar to that in tll mutant embryos;
(2) mutation of Atro in tll mutant embryos enhances the
kni derepression; and (3) Atro is naturally present in a
region within the kni promoter containing a defined
Tll-binding site, as demonstrated by chromatin
immunoprecipitation assays.
A recent report reveals that regulation of kni by Atro also
involves another nuclear protein, called Brakeless (Bks,
also referred to as Scribbler, Sbb). Mattias Mannervik’s
group (Stockholm University, Sweden) reported that Atro
and Bks/Sbb physically and genetically interact with each
other to regulate kni expression [Haecker et al., 2007].
This finding resonates with an earlier report from Gerard
Campbell’s group at the University of Pittsburgh, which
showed that Atro interacts genetically with sbb to repress
the expression of several genes, including thickveins,
runt, aristaless and Bar, in fly imaginal discs [Wehn and
Campbell, 2006]. Mannervik’s group further demonstrated
that a human homolog of Bks/Sbb, zinc finger protein 608
(ZNF608), can also interact with ATN1 directly [Haecker
et al., 2007]. Based on this finding, it is possible that
ZNF608 and another Bks/Sbb-related protein, ZNF609,
may be involved in nuclear receptor signaling in
vertebrates as well.
Aside from Tll/Tlx, our data also show that Atrophin
proteins interact with additional nuclear receptors. For
example, Atrophin proteins bind several members of the
NR2F group, including human chicken ovalbumin
upstream promoter-transcription factor (COUP-TF) and
its Drosophila homologue Seven-Up (SVP) [Wang et al.,
2006].This result was somewhat surprising, because
NR2F proteins are also known to interact with SMRT
family corepressor proteins [Bailey et al., 1997; Shibata
et al., 1997], including SMRT (silencing mediator of
retinoid and thyroid hormone receptors) [Chen and Evans,
1995], N-CoR (nuclear receptor corepressor) [Horlein et
al., 1995], and Drosophila SMRTER (SMRT-related
ecdysone receptor interacting factor) [Tsai et al., 1999].
Therefore, certain nuclear receptors, like COUP-TF/SVP,
are able to bind two classes of nuclear receptor
corepressors, perhaps by means of flexible structural
configurations.Whether Atrophin- and SMRT-family
proteins bind COUP-TF/SVP in a competitive or a
collaborative manner, and whether Atrophin proteins can
interact with additional nuclear receptors, are important
questions that still wait to be addressed.
Structural and functional domains
The strong transcriptional repressive activity associated
with Atrophin proteins has been reported by numerous
laboratories. For example, mutations of Atro cause
derepression of several segmentation gap genes in
Drosophila [Erkner et al., 2002]; Atro binds the
transcriptional repressor Even-skipped (Eve) and
mediates its transcriptional repressive effect [Zhang et
al., 2002]; Atro and ATN1 can provide a heterologous
Gal4 DNA-binding domain the ability to repress gene
transcription in Drosophila [Zhang et al., 2002]; and the
N-terminal regions of both RERE and Atro mediate strong
histone deacetylase (HDAC) activities [Wang et al., 2006].
The properties associated with each functional domain
of the Atrophin proteins described below thus help explain
how Atrophin proteins exert potent repression to regulate
gene transcription.
As shown in Figure 1, ATN1 is a smaller protein (1191
aa), compared to RERE (1566 aa) and to Atro (1966 aa)
[Erkner et al., 2002; Koide et al., 1994; Nagafuchi et al.,
1994;Yanagisawa et al., 2000; Zhang et al., 2002]. Unlike
ATN1 and Atro, RERE does not contain any long
glutamine-repeat tract.There are two regions located in
the C-terminus of RERE that are conserved in ATN1 (the
percentages of their identical and similar sequences are
shown in Figure 1). Some sequences in the second (the
C-terminal) conserved region can also be found in Atro.
The functional importance of this conserved region is
reflected in its coding of the Atro-box, which is essential
for Atrophin proteins to interact with Tll and Tlx [Wang et
al., 2006].
ATN1 resembles a truncated version of RERE because
it lacks the entire N-terminal region of RERE that harbors
several functional domains such as the BAH (bromo
adjacent homology) domain, the ELM2 (EGL-27 and
MTA1 homology 2) domain, and the SANT
(SWI3/ADA2/N-CoR/TFIII-B) domain, as well as a zinc
finger (ZnF) GATA-like motif. Among these domains, only
the ELM2 and SANT domains can be found in Atro.The
conservation of these two domains in both RERE and
Atro implies that they are functionally important. Because
BAH domain and the GATA-like motif are unique to
RERE, it is anticipated that RERE has additional
properties that do not apply to Atro.
The RE-repeats
One unique feature in the sequences of Atrophin proteins
is their coding of dipeptide repeats.The dipeptide consists
of either arginine-glutamic acid (RE), lysine-glutamic acid
(KE), arginine-aspartic acid (RD), or lysine-aspartic acid
(KD). For convenience, and to be consistent with earlier
reports, we refer to these dipeptide repeats as
RE-repeats. RERE contains three such repeats: one is
located at its very N-terminal end and the other two reside
in its C-terminal region. ATN1 has two RE-repeats
occupying positions similar to those in the C-terminus of
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The exact functions of such RE-repeats are currently
unclear, although it has been suggested that they are
involved in mediating the interaction between RERE and
ATN1 [Yanagisawa et al., 2000].
The ELM2 domain
This domain was first described in a C. elegans protein,
EGL-27 [Herman et al., 1999], which is a nuclear protein
involved in embryonic patterning, cell polarity, cell
migration, and vulval development [Herman et al., 1999;
Solari and Ahringer, 2000; Solari et al., 1999]. Based on
its sequence, EGL-27 is likely to be an ortholog of
Atrophin in the nematode C. elegans.Therefore, EGL-27
may be involved in nuclear receptor signaling in C.
elegans.The ELM2 domain can also be found in many
other transcriptional regulators, for example, vertebrate
and invertebrate MTA1, 2, 3 (metastasis-associated
proteins), CoREST (corepressor of REST), and MIER1
(mesoderm induction early response 1) [Andres et al.,
1999; Bowen et al., 2004; Ding et al., 2003].The functions
of these different nuclear factors have been under
intensive investigation. For instance, MTAs are
components of the nucleosome remodeling and histone
deacetylase (NuRD) complex [Xue et al., 1998; Zhang et
al., 1998], whose other components include
ATP-dependent chromatin remodeling protein Mi-2/CHD4
(chromodomain helicase DNA binding protein 4), HDAC
1/2 (histone deacetylase 1 and 2), MBD (methyl CpG
binding protein) 2/3, and histone interacting proteins
RbAp48/p46. Elevated expression of MTA proteins has
been associated with several metastatic cancers [Bowen
et al., 2004; Manavathi et al., 2007]; CoREST is required
for REST/NRSF (RE1-silencing transcriptional factor, also
called neuron-restrictive silencer factor) to silence the
expression of several neural-specific genes [Andres et
al., 1999]; and MIER1 is expressed at a higher level in
several breast carcinoma cell lines and breast tumors
[Paterno et al., 2002]. Owing to the studies by Ding et al.
and our laboratory, one of ELM2’s key functions has been
demonstrated to be the recruitment of HDAC1/2 [Ding et
al., 2003;Wang et al., 2006].
The SANT domain
This domain is a 50-amino acid-motif that was first
reported in 1996. It is present in many factors involved
in transcriptional regulation [Aasland et al., 1996; Boyer
et al., 2004]. Sequence and structure analyses indicate
that the SANT domain consists of three α-helices [de la
Cruz et al., 2005; Grune et al., 2003], and is homologous
to the DNA-binding domain (DBD) of c-Myb related
proteins. Despite this similarity, no report has shown that
the SANT domain can bind DNA. Instead, it codes for
diverse functions. For example, (1) a SANT domain of
ADA2 and SMRT interacts with histone tails [Boyer et al.,
2002;Yu et al., 2003]; (2) a SANT domain of SMRT binds
to and activates histone deacetylase 3 (HDAC3)
[Guenther et al., 2001]; (3) the SANT domain of MIER1
binds Sp1 and interferes with its transcriptional activating
activity [Ding et al., 2004]; (4) a SANT domain enables
CoREST to stimulate the histone demethylation activity
of LSD1 (lysine specific demethylase 1) [Shi et al., 2005];
(5) the SANT domain is essential for RERE to form
nuclear foci [Wang et al., 2006]; and (6) the SANT domain
of RERE binds G9a [Wang et al., 2008], which is a major
histone H3-lysine 9 methyltransferase [Rice et al., 2003;
Tachibana et al., 2002].These results suggest that SANT
is a versatile domain whose properties may be determined
not only by its coding sequence, but also by other regions
of the proteins within which it resides. Interestingly, many
SANT-domain proteins, including vertebrate and
invertebrate MTAs, CoREST, MIER-1, also contain the
ELM2 domain.The conjoined conservation of both
domains in various transcriptional regulators reveals not
only their functional importance, but also their potential
connection.
The BAH domain
This domain was first identified in the chick Polybromo-1
protein, which also contains multiple bromo domains
[Nicolas and Goodwin, 1996].The human homolog of
Polybromo-1, called BAF180, is a component of the
SWI/SNF chromatin remodeling complex PBAF
(polybromo, BRG-1 associated factors) [Xue et al., 2000].
The BAH domain is also present in a wide range of
proteins, including all three MTA proteins, a trithorax
group protein ASH1 (absent, small, or homeotic discs 1),
eukaryotic DNA (cytosine-5) methyltransferases, the Orc1
(origin recognition complex 1) proteins, Sir3 (silent
information regulator 3), and yeast RSC1/2 (remodeling
the structure of chromatin 1/2) [Callebaut et al., 1999;
Goodwin and Nicolas, 2001]. One characterized function
of the BAH domain is to mediate the interaction between
Orc1 and Sir1, which plays a key role in establishing the
silent chromatin structure at the cryptic mating-type loci
HMR and HML in yeast [Triolo and Sternglanz, 1996].
The same group (Rolf Sternglanz, Stony Brook University)
also reported that the BAH domain is crucial for the
function of Sir3 in transcriptional silencing [Connelly et
al., 2006]. Recently, the BAH domain of yeast Sir3 was
reported to bind to nucleosome and histone tails [Onishi
et al., 2007].
The information discussed above suggests that Atrophin
proteins, through their multiple functional domains, can
act as scaffolds for recruiting various transcriptional
cofactors, which, in turn, enable Atrophin proteins to
effectively repress transcription.This view is supported
by our recent finding that the ELM2 and SANT domains
of RERE can recruit multiple proteins in human cells
[Wang et al., 2008].This finding also resonates with two
earlier reports that MTA proteins and CoREST (which
are ELM2-SANT domain proteins) are components of
large protein complexes whose properties range from
chromatin remodeling and histone deacetylation to
transcriptional repression [Bowen et al., 2004; Manavathi
et al., 2007; Xue et al., 1998; Zhang et al., 1998]. Since
the transcriptional properties of the Atrophin proteins
depend on their associated factors, these factors create
pathways through which different developmental or
environmental cues can modify the properties of Atrophin
proteins in a context-dependent manner (Figure 2).
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processes. Atrophin proteins, such as RERE and Atro, use their ELM2 and SANT domains to recruit HDAC1/2, G9a, and additional chromatin-modifying
factors (marked as X, Y, and Z).The coordinated actions of these chromatin-modifying factors enable Atrophin proteins to promote methylation of
histone H3-K9 (a hallmark of repression) and change local chromatin structures where Atrophin-associated transcriptional factors (TF) bind. Each
Atrophin-associated chromatin-modifying factor represents a target that can be modified by EGFR (epidermal growth factor receptor) signaling and
that can be used for screening chemical compounds/drugs for treating DRPLA (dentatorubral-pallidolusian atrophy) or AML1(acute myeloid leukemia
1).
Connections with histone modification
Histone tails are subject to different covalent
modifications, including acetylation, methylation,
phosphorylation and ubiquitination [Strahl and Allis, 2000].
A large body of evidence suggests that controlling the
interplay among such modifications is a strategy used by
transcription factors or cofactors to regulate gene
transcription [Zhang and Reinberg, 2001]. Considerable
evidence has already shown that histone deacetylation
is responsible for creating specific chromatin structures
that favor transcriptional repression. Another major
histone modification implicated in transcriptional
repression is histone lysine methylation, with methylation
of histone H3 lysine 9 (H3-K9) being an important marker
of heterochromatin and silenced euchromatin [Jenuwein
and Allis, 2001; Rea et al., 2000].
Our recent data indicate that Atrophin proteins bring about
transcriptional repression by drawing on both histone
deacetylation and histone H3-K9 methylation. As
described above, RERE, via its ELM2 domain, recruits
HDAC1 and HDAC2 [Wang et al., 2006] and, through its
SANT domain, recruits the histone H3-K9
methyltransferase G9a [Wang et al., 2008]. In studying
the properties of the ELM2 and SANT domains of RERE,
we found that, by coordinating the action of HDAC1/2
and G9a, these two domains of RERE catalyze sequential
molecular events that first cause the deacetylation of
H3-K9 and then allow this deacetylated residue to be
methylated by G9a [Wang et al., 2008]. As a result of
these modifications of H3-K9, chromatin structures at the
regions where RERE binds become compact and favor
gene silencing (see the model shown in Figure 2).This
mode of action may also apply to other transcriptional
regulators containing the ELM2 and SANT domains, since
our data additionally show that all three MTA proteins
and MIER1 not only interact with HDAC1/2, but also bind
G9a [Wang et al., 2008].
Connections with EGFR signaling
The Atrophin-HDAC1/2-G9a complex is also linked to the
EGFR signaling pathway in Drosophila [Wang et al.,
2008]. As mentioned earlier, wing vein formation is
initiated by the activated EGFR in Drosophila
[Martin-Blanco et al., 1999]. In keeping with the report
that Atro acts as a negative factor in the EGFR signaling
pathway [Charroux et al., 2006], mutation of Atro or
reduced expression of Atro (using the double-stranded
RNA method) results in ectopic vein formation in the
intervein regions [Charroux et al., 2006; Kankel et al.,
2004;Wang et al., 2008].This observed mutant
Atro-mediated ectopic wing vein phenotype is enhanced
when G9a or Rpd3 (the fly HDAC1/2) is also mutated
[Wang et al., 2008].These genetic data indicate that Atro,
dG9a and Rpd3 act together to repress wing vein
formation, perhaps by antagonizing the activities of EGFR.
Strong genetic interaction among Atro, dG9a and Rpd3
also takes place in other tissues. For example, melanotic
masses appear in the Drosophila head when both Atro
and dG9a or Rpd3 are removed or mutated.We surmise
that the formation of these melanotic masses is a result
of accumulated hemocytes.Whether this phenotype
involves a hyperactive EGFR signaling pathway remains
to be investigated.
Atrophin appears to be involved in growth-factor signaling
pathways in other species as well. Julie Ahringer’s group
(University of Cambridge, UK) has shown that EGL-27,
the worm Atrophin-like protein, acts to inhibit vulval
development in C. elegans by antagonizing Ras signaling
[Solari and Ahringer, 2000], which takes place
downstream of growth-factor signaling pathways.
Therefore, negative regulation of the EGFR-Ras pathway
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and their associating factors. Since hyperactive EGFR
and Ras are associated with various cancers, their
oncogenic effects may result from their interference with
the transcriptional repressive properties of the
Atrophin-HDAC1/2-G9a protein complex.
Janus-faced transcriptional properties,
and beyond transcription
Owing to their relationship with transcriptional repressors
and HDACs, Atrophin proteins have been viewed primarily
as dedicated corepressors. However, considerable
evidence suggests that Atro can regulate gene
transcription in a positive manner as well. For example,
Ian Duncan’s group (Washington University, St. Louis)
reported that ftz expression is reduced in Drosophila
embryos mutant of Atro [Kankel et al., 2004]. In the same
report, they provided additional evidence suggesting that
Atro is a member of the trithorax group (trxG) proteins,
which are known to regulate the expression of homeotic
genes positively.Their evidence includes: (1) mutations
of Atro enhance the loss-of-function phenotypes of
antennapedia complex and bithorax complex genes; (2)
the phenotypes caused by the mutations of two trxG
genes, brahma and trithorax, are enhanced by mutations
of Atro; and (3) the leg phenotype caused by mutations
in Polycomb-like, a polycomb group (PcG) gene, is
suppressed by mutations of Atro. (Note that PcG genes
have opposite effects from trxG genes on regulating the
expression of homeotic genes.)
In many respects, the observed behavior of Atro
resembles that of Osa, as also suggested by Ian Duncan’s
group. Osa is a trxG group protein known to associate
with the Brahma chromatin remodeling complex [Collins
et al., 1999;Vazquez et al., 1999].While the functions of
Osa have been associated primarily with transcriptional
activation, it has been linked with transcriptional
repression as well. For example, Jessica Treisman’s
group (Skirball Institute, New York University) showed
that several wingless target genes are repressed by Osa
[Collins and Treisman, 2000].Therefore, both Atro and
Osa may be bifunctional transcriptional regulators whose
transcriptional properties (either positive or negative) can
be influenced by other factors or by posttranslational
modifications.This idea is further supported by the finding
that the C-terminal region of RERE contains a domain
that can activate gene transcription through its association
with the transcriptional coactivator p300 [Shen et al.,
2007]. Since our recent data indicate that RERE is subject
to protein cleavage [Wang et al., 2008], the cleavage
event—which allows the C-terminal transcriptional
activating module to be separated from the N-terminal
transcriptional repressive module—could be responsible
for converting RERE from a transcriptional repressive
form to a transcriptional activating form. My laboratory is
currently investigating this possibility.
Although Atro has been investigated predominantly as a
nuclear protein, Helen McNeill’s group (Samuel Lunenfeld
Research Institute, Mt. Sinai Hospital, Canada) has
reported that Atro physically interacts with the cytoplasmic
domain of the atypical cadherin Fat in vitro [Fanto et al.,
2003], and that Atro collaborates with Fat to control planar
polarity in the Drosophila eye.These results suggest that
Atro might have non-nuclear functions as well.
Furthermore, ATN1 localizes predominantly to the
cytoplasm of neuronal cells [Knight et al., 1997], and can
interact with several proteins with functions outside the
realm of transcriptional regulation. Several
ATN1-interacting proteins (AIPs) isolated from yeast two
hybrid screens [Wood et al., 1998] are known to function
in the cytoplasm. For example, AIP1 is a
membrane-associated guanylate kinase family protein
that interacts with the tumor suppressor PTEN and
enhances its ability to suppress Akt activation [Wu et al.,
2000]. AIP4 is an ubiquitin E3 ligase, which regulates the
degradation of the human enhancer of filamentation 1
(HEF1) in TGF-β (transforming growth factor β) signaling
pathways [Feng et al., 2004]. ATN1 may also function in
an insulin-related signaling pathway, since ATN1 can
bind the SH3 (Src homology 3) domain of a human
homologue of the insulin receptor tyrosine kinase
substrate protein of 53kD (IRSp53) in the cytoplasm
[Okamura-Oho et al., 1999].
A comparison between the Atrophin-
and SMRT-family proteins
In many respects, the functional properties discovered
for Atrophin family proteins resemble those found for
SMRT family proteins, which are, by far, the best
characterized nuclear receptor corepressors. Aside from
their functional resemblance, these two groups of nuclear
receptor corepressors also exhibit their own unique
features. A comparison of their known properties is
described below and summarized in Figure 3.
(1) Both families' proteins are conserved. Each includes
a Drosophila protein (Atro and SMRTER), and two
vertebrate paralogues (ATN1, RERE and SMRT, N-CoR)
[Chen and Evans, 1995; Erkner et al., 2002; Horlein et
al., 1995; Koide et al., 1994; Nagafuchi et al., 1994;Tsai
et al., 1999;Yanagisawa et al., 2000; Zhang et al., 2002].
All of these proteins contain RE-repeats and all, except
ATN1, also contain one or two SANT domains. Moreover,
all proteins in both groups, except RERE, contain at least
one glutamine-tract.
(2) Both families' proteins interact with nuclear receptors
in a selective way. SMRT, N-CoR and SMRTER
preferentially bind nuclear receptors, such as retinoic acid
receptor (RAR), thyroid hormone receptor (TR),
peroxisome proliferator-activated receptor (PPAR) and
ecdysone receptor (EcR) [Jepsen and Rosenfeld, 2002;
Lazar, 2003; Privalsky, 2001;Tsai and Fondell, 2004],
but not Tll and Tlx [Wang et al., 2006]. Atrophin proteins,
in contrast, interact strongly with Tll and Tlx, but barely
with RAR, TR, PPAR or EcR [Wang et al., 2006].Their
differential affinity towards different groups of nuclear
receptors may result from the different structural motifs
these two groups of proteins use to interact with nuclear
receptors. For example, Mitch Lazar’s group (University
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Review An overview of atrophin proteinsFigure 3.  A comparison of the known properties of SMRT- and Atrophin- proteins. The well characterized SMRT class of corepressors,
including SMRT (silencing mediator of retinoid and thyroid hormone receptors), N-CoR (nuclear receptor corepressor), and their Drosophila cognate
SMRTER (SMRT-related ecdysone receptor interacting factor), preferentially bind members of subgroup 1 of the nuclear receptor superfamily, such
as TR (thyroid hormone receptor), RAR (retinoic acid receptor), or EcR (ecdysone receptor), and recruits HDAC3.The newly-identified Atrophin class
of corepressors, including RERE, ATN1, and their Drosophila cognate Atro, in contrast, selectively bind members of the subgroup 2 of nuclear receptors,
such as Tll and Tlx, and recruits HDAC1/2. (Note: Rpd3 is the fly HDAC1/2).Whereas Atrophin proteins, except for ATN1, bind G9a both in mammalian
cells and in fly, none of the members of the SMRT family proteins have so far been shown to bind HMTases. RXR (retinoid-X receptor) and USP
(Ultraspiracle, the fly RXR), are the common binding partners of RAR and TR, and EcR, respectively.
of Pennsylvania) identified a CoRNR box (or L/I-X-X-I/V-I
motif) in both SMRT and N-CoR that enables both
proteins to interact with nuclear receptors [Hu and Lazar,
1999].We identified a stretch of highly conserved amino
acids, termed the Atro-box (Figure 1), in all Atrophin
proteins that are essential for them to bind Tll and Tlx
[Wang et al., 2006].
(3) Both families' proteins interact with HDACs, also in a
selective way. SMRT and N-CoR bind HDAC3 strongly
[Guenther et al., 2000; Li et al., 2000], while their
associations with HDAC1 and HDAC2 are relatively weak
[Wang et al., 2006]. Atrophin proteins show the opposite
preferences, with Atro and RERE strongly interacting with
HDAC1 and HDAC2, but barely with HDAC3 [Wang et
al., 2006]. Considering that SMRT proteins can also bind
to type II HDACs, such as HDAC 4, 5, and 7 [Huang et
al., 2000; Kao et al., 2000], it is possible that Atrophin
proteins may associate selectively with type II HDACs as
well.
(4) Atrophin proteins, except ATN1, associate with
HMTases such as G9a [Wang et al., 2008]. Although
direct interactions between SMRT family proteins and
HMTase have not been reported, data from our laboratory
indicate that transcriptional repression mediated by SMRT
family proteins also involves HMTases.This finding,
together with the results described above, suggests that
recruiting both HDACs and HMTases is an important and
shared strategy used by nuclear receptor corepressors
to repress gene transcription.
Implications for diseases
DRPLA
Polyglutamine expansion within human ATN1 causes
DRPLA, which is also known as Haw River Syndrome
and Naito-Oyanagi disease. DRPLA is one of the nine
late-onset polyglutamine neurodegenerative diseases,
which also include Huntington’s disease, spinobulbar
muscular atrophy, and spinal cerebellar ataxias 1, 2, 3,
6, 7, and 17 [Zoghbi and Orr, 2000].The clinical features
of DRPLA include dementia, choreoathetosis, myoclonus
epilepsy, and ataxia [Tsuji, 1999]. Like most polyglutamine
diseases, the pathogenic mechanism underlying DRPLA
remains elusive. It had been speculated that
glutamine-repeat expansion in ATN1 compromises its
own function.This view, however, has been challenged
by a recent report that Atn1
-/-  mice show no neurological
defects or other phenotype [Shen et al., 2007].Therefore,
the dominant negative effect caused by the
glutamine-repeat expanded form of ATN1 is likely
mediated through pathways other than a simple loss of
function of ATN1.
Several models have been proposed to explain the
neurotoxicity caused by mutant ATN1, including the
formation of nuclear aggregates or inclusions, which is a
hallmark of polyglutamine diseases [Ross and Poirier,
2004], protein cleavage of ATN1 [Ellerby et al., 1999;
Nucifora et al., 2003; Schilling et al., 1999], and
phosphorylation of ATN1 [Okamura-Oho et al., 2003].
Thus far, the exact roles of such modifications of ATN1
in the pathogenesis of DRPLA have not been firmly
established.With regard to protein cleavage, a caspase-3
cleavage site was mapped to the Asp109 of ATN1;
expressing this cleaved form of ATN1 causes cytotoxicity
in cultured cells [Ellerby et al., 1999]. Although the in vivo
relevance of this cleaved form of ATN1 to DRPLA
development is still unclear, the fact that ATN1 is involved
in transcriptional regulation suggests that this cleavage
event might affect its transcriptional (and perhaps toxic)
properties.
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potential pathogenic mechanism responsible for many
polyglutamine diseases [Riley and Orr, 2006].The
glutamine-repeat expanded form of ATN1 interacts
strongly with TAFII130 and can suppress
CREB-dependent transcriptional activation [Shimohata
et al., 2000]. CBP is sequestered into nuclear inclusions
found in DRPLA postmortem brain tissue, and the
N-terminal truncation of the expanded ATN1 can inhibit
CBP-mediated transcription [Nucifora et al., 2001].
Correlatively, a DRPLA transgenic mouse model
expressing ATN1 with 118Q exhibits hypoacetylation of
histone H3 in brain tissues, whereas the administration
of sodium butyrate, an HDAC inhibitor, ameliorates the
neurodegenerative phenotypes of such mice [Ying et al.,
2006].These observations strongly suggest that abnormal
gene repression is a contributing factor for the
development of DRPLA.
Although sequestration of CBP into ATN1-mediated
nuclear inclusions may partly account for mutant
ATN1-mediated changes in gene expression profile and
neurotoxicity, other mechanisms may also be involved.
With our recent identification of Atrophin proteins as
nuclear receptor corepressors, one plausible explanation
for the development of DRPLA is that nuclear receptor
signaling pathways are perturbed. It is noteworthy that
ATN1's interacting partners, such as Tlx and COUP-TF,
are expressed and function in the nervous system
[Miyawaki et al., 2004; Park et al., 2003; Roy et al., 2002;
Shi et al., 2004;Tripodi et al., 2004;Yu et al., 1994].The
pathogenesis of DRPLA might also involve RERE,
considering that RERE can dimerize with ATN1 and that
RERE-ATN1 interaction is enhanced when ATN1’s
glutamine-repeat is expanded [Yanagisawa et al., 2000].
In fact, the latter model is supported by the effects caused
by ATN1 in Drosophila: expressing a pathological form
of ATN1 in Drosophila generates a phenotype similar to
that caused by mutations of Atro [Charroux et al., 2006].
We here propose several mechanisms that might explain
how ATN1 affects Atro-dependent pathways in
Drosophila: (1) The functions of Atro may be
compromised upon its association with the insoluble form
of mutant ATN1; (2) stabilized mutant ATN1 may compete
with Atro to bind common transcriptional cofactors; and
(3) a stabilized mutant ATN1, which lacks intrinsic HDAC
and HMTase activities [Wang et al., 2008;Wang et al.,
2006], might gain both chromatin-modifying activities
upon its association with Atro. Any of these hypothesized
mechanisms would affect the transcriptional properties
of Atro in Drosophila.With the observed effects of ATN1
in Drosophila in mind, one tempting theory for the
mechanism of DRPLA in vertebrates is that the functions
of RERE are affected by mutant ATN1. If so, we predict
that the phenotypes displayed by DRPLA mice will be
enhanced when one allele of the Rere gene is removed
or mutated.
Cancers
The gene for Rere is located in the distal region of
chromosome 1p, where frequent structural
rearrangements have been reported in association with
several human malignancies [Schwab et al., 1996]. For
example, the neuroblastoma cell line NGP contains a
reciprocal chromosomal translocation/duplication
t(1;15)(p36.2;q24), Dp(1)(p36.2-p36.3) [Casciano et al.,
1996]. It has been reported that the Rere gene unit is
disrupted in NGP [Amler et al., 2000]. Additionally, the
expression of Rere transcripts is altered in many
neuroblastoma cell lines [Waerner et al., 2001]. In cultured
cells, transiently overexpressed RERE colocalizes with
BAX, a proapoptotic protein, and enhances
caspase-dependent apoptosis [Waerner et al., 2001].The
latter result implies that mutation of Rere may prevent
damaged cells from undergoing cell death, thus leading
to cancer development.
ATN1 has also been shown to interact with ETO/MTG8
[Wood et al., 2000], a transcriptional coregulator whose
fusion with RUNX1 causes the most common form of
t(8;21) acute myeloid leukemia (AML) [Kozu et al., 1993;
Miyoshi et al., 1993; Nisson et al., 1992]. Interestingly,
ETO/MTG8 has been shown previously to be an
associating factor of SMRT, N-CoR, Sin3A and HDACs
[Gelmetti et al., 1998; Lutterbach et al., 1998;Wang et
al., 1998].The association between ETO/MTG8 and
various transcriptional corepressors suggests that
aberrant transcriptional repression imposed on
RUNX1-regulatory pathways by the ETO-RUNX1 fusion
protein could be an underlying reason for the
pathogenesis of AML1. If so, reducing the transcriptional
repressive activities of either or both Atrophin-family and
SMRT-family proteins could provide a feasible therapeutic
strategy for treating AML1.
Therapeutic implications
Abnormal expression levels of MTAs and MIER1 have
been linked to different forms of metastatic tumors or
different carcinoma cell lines [Bowen et al., 2004; Ding
et al., 2003; Kumar et al., 2003;Waerner et al., 2001].
Since our recent work shows that these proteins are
associated with HDAC1/2 and G9a [Wang et al., 2008],
we suspect that alteration of their expression levels may
cause aberrant transcriptional repression and,
consequently, may result in the development or
progression of cancers. Recently, HDAC inhibitors [Marks
et al., 2001] have been tested as promising agents in
treating blood-borne cancers, and also in treating
polyglutamine diseases [Carey and La Thangue, 2006;
Hockly et al., 2003; McCampbell et al., 2001; Minamiyama
et al., 2004; Steffan et al., 2001;Ying et al., 2006]. Since
specific G9a inhibitors have also been recently reported
by Thomas Jenuwein’s lab at the Vienna Biocenter,
Austria [Kubicek et al., 2007], our study raises the
possibility that these G9a inhibitors might also be used,
alone or together with the current FDA-approved HDAC
inhibitors, for treating cancers and neurological diseases
involving Atrophin, MTAs, CoREST or MIER1 (Figure 2).
Concluding remarks
Rapid progress during the past few years has produced
a much better understanding of the Atrophin protein
www.nursa.org  NRS  | 2008 |  Vol. 6 |  DOI: 10.1621/nrs.06009 | Page 9 of 13
Review An overview of atrophin proteinsfamily's molecular functions.The exciting discovery that
Atrophin proteins are nuclear receptor corepressors
enables us to look at these proteins from a nuclear
receptor signaling perspective. Our efforts make it clear
now that Atrophin proteins employ mechanisms, such as
histone deacetylation and histone lysine methylation, to
repress gene transcription. It is only a matter of time
before more nuclear receptors, transcriptional factors,
and histone/chromatin-modifying factors are identified
that associate with Atrophin proteins. In-depth study of
Atrophin proteins and their functions in connection with
nuclear receptor, EGFR, and chromatin-modifying factors
will not only lead to a better understanding of their roles
in animal development and in human diseases, but will
also pave the way for the identification of potential
therapeutic targets for treating various human diseases.
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